Back
Monte Rosa Therapeutics Quote, Financials, Valuation and Earnings
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
34
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Monte Rosa Therapeutics Price Quote
$8.49
-0.14 (-1.57%)
(Updated: November 14, 2024 at 5:55 PM ET)
Monte Rosa Therapeutics Key Stats
Sell
34
Monte Rosa Therapeutics (GLUE)
is a Sell
Day range:
$8.62 - $9.60
52-week range:
$2.91 - $12.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.49%
Volume:
668.9K
Avg. volume:
4.2M
1-year change:
182.32%
Market cap:
$559.7M
Revenue:
$0
EPS:
$-2.24
How Much Does Monte Rosa Therapeutics Make?
Data Unavailable
Is Monte Rosa Therapeutics Growing As A Company?
Data Unavailable
Monte Rosa Therapeutics Stock Price Performance
-
Did Monte Rosa Therapeutics Stock Go Up Last Month?
Monte Rosa Therapeutics share price went up by 74.95% last month -
Did GLUE's Share Price Rise Over The Last Year?
GLUE share price rose by 182.32% over the past 1 year
What Is Monte Rosa Therapeutics 52-Week High & Low?
-
What Is Monte Rosa Therapeutics’s 52-Week High Share Price?
Monte Rosa Therapeutics has traded as high as $12.40 over the past 52 weeks -
What Is Monte Rosa Therapeutics’s 52-Week Low Share Price?
Monte Rosa Therapeutics has traded as low as $2.91 over the past 52 weeks
Monte Rosa Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Monte Rosa Therapeutics?
-
How Much Debt Does Monte Rosa Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Monte Rosa Therapeutics Have?
Cash and short term investments quarterly total is $262.2M -
What Is Monte Rosa Therapeutics’s Book Value Per Share?
Book value per share is 3.66
Is Monte Rosa Therapeutics Cash Flow Positive?
-
What Is GLUE Cash Flow From Operations?
Cash flow from operations (TTM) is -$61M -
What Is Monte Rosa Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $124.5M -
What Is Monte Rosa Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.4M
Monte Rosa Therapeutics Return On Invested Capital
Data Unavailable
Monte Rosa Therapeutics Earnings Date & Stock Price
-
What Is Monte Rosa Therapeutics's Stock Price Today?
A single share of GLUE can be purchased today for 8.63 -
What Is Monte Rosa Therapeutics’s Stock Symbol?
Monte Rosa Therapeutics trades on the nasdaq under the ticker symbol: GLUE -
When Is Monte Rosa Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Monte Rosa Therapeutics is scheduled on March 14, 2025 -
When Is GLUE's next ex-dividend date?
Monte Rosa Therapeutics's next ex-dividend date is November 15, 2024 -
How To Buy Monte Rosa Therapeutics Stock?
You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Monte Rosa Therapeutics Competitors
-
Who Are Monte Rosa Therapeutics's Competitors?
Below is a list of companies who compete with Monte Rosa Therapeutics or are related in some way:
Monte Rosa Therapeutics Dividend Yield
-
What Is GLUE Dividend Yield?
Monte Rosa Therapeutics’s dividend yield currently is 0% -
What Is Monte Rosa Therapeutics’s Payout Ratio?
Monte Rosa Therapeutics’s payout ratio is 0% -
When Did Monte Rosa Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Monte Rosa Therapeutics’s Dividend Per Share?
Monte Rosa Therapeutics pays a dividend of $0.00 per share
Monte Rosa Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 38.42% |
| Revenue: | 0% | 183.67% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 16.43 |
| Upside from Last Price: | 90.48% |